Abstract:Background: Viral-induced interleukin (IL)-10 and regulatory T lymphocytes (Tregs) are believed to play a major role in shaping the immunological and clinical outcomes following Porcine Reproductive and Respiratory Syndrome virus (PRRSV) infection. Recently, it has been shown that PRRSV nucleocapsid (N) protein can induce IL-10 production which is essential for induction of PRRSV-specific Tregs. We hypothesized that immunity to N protein should reduce PRRSV-induced negative immunomodulatory effects which will be essential for establishing proper anti-PRRSV immunity in infected pigs. Objectives: To investigate the immunomodulatory effects of DNA vaccine encoding a linearized, truncated form of PRRSV-N protein (pORF7t) which was designed to preferentially induce cell-mediated immunity against PRRSV N protein. Method: Immunomodulatory effects of the novel DNA vaccine were investigated in an experimental vaccinated-challenged model. In addition, long-term immunomodulatory effects of the DNA vaccine were investigated in vaccinated pigs kept at the PRRSV-positive environment until the end of the fattening period. Pigs were vaccinated either prior to or following natural PRRSV infection. Result: The results indicated that pORF7t could modulate the anti-PRRSV immune responses and promote the control of viral replication in the vaccinated-challenged pigs. Immunized pigs exhibited increased numbers of PRRSV-specific activated CD4(+)CD25(+) lymphocytes, reduced numbers of PRRSV-specific Tregs, and rapid viral clearance following infection. In a long-term study, regardless of the time of vaccination, DNA vaccine could modulate the host immune responses, resulted in enhanced PRRSV-specific IFN-γ producing cells, and reduced numbers of PRRSV-specific Tregs, without evidence of enhanced antibody responses. No vaccine adverse reaction was observed throughout the study. Conclusion: This study revealed the novel concept that PRRSV-specific immunity can be modulated by induction of cell-mediated immunity against the nucleocapsid protein. This concept could potentially benefit the development of PRRSV management and control strategies.

Progress on DNA Vaccine of Porcine Reproductive and Respiratory Syndrome

A transgenic Marc-145 cell line of piggyBac transposon-derived targeting shRNA interference against porcine reproductive and respiratory syndrome virus.

Research Progress on the Development of Porcine Reproductive and Respiratory Syndrome Vaccines

Research progress on the N protein of porcine reproductive and respiratory syndrome virus

Molecular Characterization of Three Porcine Reproductive and Respiratory Syndrome Virus Isolates and Their Susceptibility to Antiviral Drugs

Research progress in the development of porcine reproductive and respiratory syndrome virus as a viral vector for foreign gene expression and delivery

Current Status of Vaccines for Porcine Reproductive and Respiratory Syndrome: Interferon Response, Immunological Overview, and Future Prospects

The Advance in Molecular Biology of Porcine Reproductive and Respiratory Syndrome Virus

Assessment of the efficacy of two novel DNA vaccine formulations against highly pathogenic Porcine Reproductive and Respiratory Syndrome Virus

Research Progress on the Molecular Mechanism of Immune Escape of Porcine Reproductive and Respiratory Syndrome Virus

A novel DNA vaccine for reduction of PRRSV-induced negative immunomodulatory effects: A proof of concept

Construction and Immunogenicity of DNA Vaccines Encoding Fusion Protein of Porcine IFN- Λ 1 and GP5 Gene of Porcine Reproductive and Respiratory Syndrome Virus.

Improved Vaccine against PRRSV: Current Progress and Future Perspective.

Adsorption of a Porcine Reproductive and Respiratory Syndrome Virus DNA Vaccine Candidate Onto Biodegradable Nanoparticles Improves Immunogenicity in Mice

Research Advances in Non-Structural Protein 2 of Porcine Reproductive and Respiratory Syn-Drome Virus

The Function of the PRRSV–Host Interactions and Their Effects on Viral Replication and Propagation in Antiviral Strategies

Immunological evaluation of recombination PRRSV GP3 and GP5 DNA vaccines <i>in vivo</i>

Recent Advances in Porcine Reproductive and Respiratory Syndrome Virus NADC30-Like Research in China: Molecular Characterization, Pathogenicity, and Control

Research Progress on the NSP10 Protein of Porcine Reproductive and Respiratory Syndrome Virus

Immunological evaluation of recombination PRRSV GP3 and GP5 DNA vaccines in vivo

Evaluation of a DNA Vaccine Candidate Co-Expressing GP3 and GP5 of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) with Interferon Α/γ in Immediate and Long-Lasting Protection Against HP-PRRSV Challenge